scholarly article | Q13442814 |
P50 | author | Maciej Goniewicz | Q60585417 |
Hayden McRobbie | Q75237858 | ||
P2093 | author name string | Peter Hajek | |
Oliver West | |||
Anna Phillips | |||
Katie Myers Smith | |||
P2860 | cites work | Do e-cigarettes have the potential to compete with conventional cigarettes?: a survey of conventional cigarette smokers' experiences with e-cigarettes | Q45768076 |
Use of electronic cigarettes among young Swiss men: Table 1 | Q57156862 | ||
Saliva cotinine levels in users of electronic cigarettes | Q59287285 | ||
Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum | Q68433728 | ||
Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function | Q73232686 | ||
Electronic cigarettes for smoking cessation | Q85748413 | ||
Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices | Q24601683 | ||
Nicotine chemistry, metabolism, kinetics and biomarkers | Q24632647 | ||
Doses of nicotine and lung carcinogens delivered to cigarette smokers | Q28142822 | ||
Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications | Q28304212 | ||
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects | Q34057919 | ||
Metabolism and disposition kinetics of nicotine | Q34398241 | ||
Female sex and oral contraceptive use accelerate nicotine metabolism | Q34522449 | ||
Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. | Q35529561 | ||
Electronic cigarettes: effective nicotine delivery after acute administration. | Q36471915 | ||
A systematic review of nicotine by inhalation: is there a role for the inhaled route? | Q37989379 | ||
MODFIT: a pharmacokinetics computer program | Q39261296 | ||
A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction | Q39285623 | ||
Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. | Q39361094 | ||
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. | Q43105728 | ||
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids | Q44851997 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nicotine | Q12144 |
P304 | page(s) | 175-179 | |
P577 | publication date | 2014-08-13 | |
P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
P1476 | title | Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. | |
P478 | volume | 17 |
Q45981593 | A comparison of daily versus weekly electronic cigarette users in treatment for substance abuse. |
Q51595604 | A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics. |
Q35688790 | Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes |
Q58095901 | Clouds and “throat hit”: Effects of liquid composition on nicotine emissions and physical characteristics of electronic cigarette aerosols |
Q35765119 | Contexts of cigarette and e-cigarette use among dual users: a qualitative study |
Q55093695 | Determination of Nicotine Content and Delivery in Disposable Electronic Cigarettes Available in the United States by Gas Chromatography-Mass Spectrometry. |
Q57710066 | Determination of Nicotine in Cartridge-Based Electronic Cigarettes |
Q34558316 | Do E-cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future |
Q36172506 | E-cigarettes and expectancies: why do some users keep smoking? |
Q26738339 | E-cigarettes for the management of nicotine addiction |
Q47432202 | E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure |
Q42742031 | E-cigarettes: a disruptive technology that revolutionizes our field? |
Q64103961 | Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial |
Q37642791 | Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke |
Q28278571 | Electronic cigarettes for smoking cessation |
Q30251965 | Electronic cigarettes: what are they and what do they do? |
Q28258421 | Factors Associated With Electronic Cigarette Users' Device Preferences and Transition From First Generation to Advanced Generation Devices |
Q58804210 | Heat or Burn? Impacts of Intrauterine Tobacco Smoke and E-Cigarette Vapor Exposure on the Offspring's Health Outcome |
Q40247028 | Impact of gestational nicotine exposure on intrauterine and fetal infection in a rodent model |
Q58096213 | Impact of power level and refill liquid composition on the aerosol output and particle size distribution generated by a new-generation e-cigarette device |
Q50147135 | Initial ratings of different types of e-cigarettes and relationships between product appeal and nicotine delivery. |
Q88339117 | Leading-Brand Advertisement of Quitting Smoking Benefits for E-Cigarettes |
Q47900356 | Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers |
Q92173234 | Nicotine absorption during electronic cigarette use among regular users |
Q35749909 | Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). |
Q39231654 | Nicotine and Carbonyl Emissions From Popular Electronic Cigarette Products: Correlation to Liquid Composition and Design Characteristics. |
Q35668491 | Nicotine and cotinine exposure from electronic cigarettes: a population approach. |
Q37639883 | Nicotine delivery to users from cigarettes and from different types of e-cigarettes |
Q36568083 | Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes |
Q35688888 | Nicotine levels in electronic cigarette refill solutions: A comparative analysis of products from the U.S., Korea, and Poland |
Q90082784 | Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial |
Q91368242 | Nicotine pharmacokinetics of electronic cigarettes: A review of the literature |
Q34546578 | Overview of Electronic Nicotine Delivery Systems: A Systematic Review |
Q90256336 | Physical and chemical assessment of 1,3 Propanediol as a potential substitute of propylene glycol in refill liquid for electronic cigarettes |
Q52308432 | Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. |
Q101403207 | Reduced levels of biomarkers of exposure in smokers switching to the Carbon-Heated Tobacco Product 1.0: a controlled, randomized, open-label 5-day exposure trial |
Q30375616 | Reinforcement enhancing effects of acute nicotine via electronic cigarettes. |
Q40587250 | The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States |
Q37243512 | The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive Technology: Results From a National Survey |
Q92188147 | Tobacco and bone fractures: A review of the facts and issues that every orthopaedic surgeon should know |
Search more.